Familial Aggregation of Autoimmune Disease in Juvenile Dermatomyositis
暂无分享,去创建一个
[1] J. Jarvis,et al. Double trouble: therapeutic challenges in patients with both juvenile dermatomyositis and psoriasis. , 2011, Archives of dermatology.
[2] J. Harley,et al. Network analysis of associations between serum interferon-α activity, autoantibodies, and clinical features in systemic lupus erythematosus. , 2011, Arthritis and rheumatism.
[3] M. Si-Tahar,et al. A loss-of-function variant of the antiviral molecule MAVS is associated with a subset of systemic lupus patients , 2011, EMBO Molecular Medicine.
[4] T. Niewold,et al. Gene-gene-sex interaction in cytokine gene polymorphisms revealed by serum interferon alpha phenotype in juvenile dermatomyositis. , 2010, The Journal of pediatrics.
[5] T. Niewold,et al. Lesional and nonlesional skin from patients with untreated juvenile dermatomyositis displays increased numbers of mast cells and mature plasmacytoid dendritic cells. , 2010, Arthritis and rheumatism.
[6] D. Scott,et al. Epidemiology of ANCA-associated vasculitis. , 2010, Rheumatic diseases clinics of North America.
[7] A. Skol,et al. Trait-stratified genome-wide association study identifies novel and diverse genetic associations with serologic and cytokine phenotypes in systemic lupus erythematosus , 2010, Arthritis research & therapy.
[8] P. Gaffney,et al. The Role of Genetic Variation Near Interferon-Kappa in Systemic Lupus Erythematosus , 2010, Journal of biomedicine & biotechnology.
[9] A. Skol,et al. Promoter Variant of PIK3C3 Is Associated with Autoimmunity against Ro and Sm Epitopes in African-American Lupus Patients , 2010, Journal of biomedicine & biotechnology.
[10] Timothy B. Niewold,et al. Interferon Alpha in Systemic Lupus Erythematosus , 2010, Journal of biomedicine & biotechnology.
[11] C. Cardwell,et al. A systematic review of population based epidemiological studies in Myasthenia Gravis , 2010, BMC neurology.
[12] E. Adams,et al. African-Derived Genetic Polymorphisms in TNFAIP3 Mediate Risk for Autoimmunity , 2010, The Journal of Immunology.
[13] Constantin Polychronakos,et al. Comparative genetic analysis of inflammatory bowel disease and type 1 diabetes implicates multiple loci with opposite effects. , 2010, Human molecular genetics.
[14] T. Niewold,et al. Genetic regulation of serum cytokines in systemic lupus erythematosus. , 2010, Translational research : the journal of laboratory and clinical medicine.
[15] M. Jolly,et al. Genetic variation at the IRF7/PHRF1 locus is associated with autoantibody profile and serum interferon-alpha activity in lupus patients. , 2010, Arthritis and rheumatism.
[16] R. Schiffer,et al. The Prevalence of Multiple Sclerosis in 3 US Communities , 2009, Preventing Chronic Disease.
[17] Xujian Li,et al. Incidence of dermatomyositis and clinically amyopathic dermatomyositis: a population-based study in Olmsted County, Minnesota. , 2010, Archives of dermatology.
[18] K. Hemminki,et al. Shared familial aggregation of susceptibility to autoimmune diseases. , 2009, Arthritis and rheumatism.
[19] T. Niewold,et al. Elevated serum interferon-alpha activity in juvenile dermatomyositis: associations with disease activity at diagnosis and after thirty-six months of therapy. , 2009, Arthritis and rheumatism.
[20] T. Niewold,et al. Age- and gender-specific modulation of serum osteopontin and interferon-α by osteopontin genotype in systemic lupus erythematosus , 2009, Genes and Immunity.
[21] J. Lamb,et al. The protein tyrosine phosphatase N22 gene is associated with juvenile and adult idiopathic inflammatory myopathy independent of the HLA 8.1 haplotype in British Caucasian patients. , 2008, Arthritis and rheumatism.
[22] T. Niewold,et al. The PTPN22 C1858T polymorphism is associated with skewing of cytokine profiles toward high interferon-alpha activity and low tumor necrosis factor alpha levels in patients with lupus. , 2008, Arthritis and rheumatism.
[23] J. Harley,et al. Association of the IRF5 risk haplotype with high serum interferon-alpha activity in systemic lupus erythematosus patients. , 2008, Arthritis and rheumatism.
[24] B. Feldman,et al. Assessment of an infectious disease history preceding juvenile dermatomyositis symptom onset. , 2008, Rheumatology.
[25] J. S. St. Sauver,et al. Epidemiology of sporadic inclusion body myositis and polymyositis in Olmsted County, Minnesota. , 2008, The Journal of rheumatology.
[26] J. Buyon,et al. Serum type I interferon activity is dependent on maternal diagnosis in anti-SSA/Ro-positive mothers of children with neonatal lupus. , 2008, Arthritis and rheumatism.
[27] S. Pillemer,et al. Augmented interferon-alpha pathway activation in patients with Sjögren's syndrome treated with etanercept. , 2007, Arthritis and rheumatism.
[28] J. Lieberman,et al. Mutations in the gene encoding the 3′-5′ DNA exonuclease TREX1 are associated with systemic lupus erythematosus , 2007, Nature Genetics.
[29] William J. Tremaine,et al. Update on the incidence and prevalence of Crohn's disease and ulcerative colitis in Olmsted County, Minnesota, 1940–2000 , 2007, Inflammatory bowel diseases.
[30] J. Harley,et al. High serum IFN-alpha activity is a heritable risk factor for systemic lupus erythematosus. , 2007, Genes and immunity.
[31] Sharon Adams,et al. Immunogenetic risk and protective factors for juvenile dermatomyositis in Caucasians. , 2006, Arthritis and rheumatism.
[32] Desmond E. Williams,et al. The Burden of Diabetes Mellitus Among US Youth: Prevalence Estimates From the SEARCH for Diabetes in Youth Study , 2006, Pediatrics.
[33] M. Crow,et al. Functional assay of type I interferon in systemic lupus erythematosus plasma and association with anti-RNA binding protein autoantibodies. , 2006, Arthritis and rheumatism.
[34] J. Anaya,et al. Familial clustering of autoimmune diseases in patients with type 1 diabetes mellitus. , 2006, Journal of autoimmunity.
[35] A. Dyer,et al. History of infection before the onset of juvenile dermatomyositis: results from the National Institute of Arthritis and Musculoskeletal and Skin Diseases Research Registry. , 2005, Arthritis and rheumatism.
[36] L. Rönnblom,et al. Activation of the type I interferon system in primary Sjögren's syndrome: a possible etiopathogenic mechanism. , 2005, Arthritis and rheumatism.
[37] Marta E Alarcón-Riquelme,et al. Familial aggregation of systemic lupus erythematosus, rheumatoid arthritis, and other autoimmune diseases in 1,177 lupus patients from the GLADEL cohort. , 2005, Arthritis and rheumatism.
[38] K. Siminovitch. PTPN22 and autoimmune disease , 2004, Nature Genetics.
[39] David J Margolis,et al. Psoriasis is common, carries a substantial burden even when not extensive, and is associated with widespread treatment dissatisfaction. , 2004, The journal of investigative dermatology. Symposium proceedings.
[40] Brenda W Gillespie,et al. Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population. , 2003, Arthritis and rheumatism.
[41] R. Cervera,et al. The epidemiology of systemic lupus erythematosus , 2003, Clinical reviews in allergy & immunology.
[42] A. Dyer,et al. US incidence of juvenile dermatomyositis, 1995-1998: results from the National Institute of Arthritis and Musculoskeletal and Skin Diseases Registry. , 2003, Arthritis and rheumatism.
[43] J. Murray,et al. Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study. , 2003, Archives of internal medicine.
[44] P. Lachenbruch,et al. Neopterin and quinolinic acid are surrogate measures of disease activity in the juvenile idiopathic inflammatory myopathies. , 2002, Clinical chemistry.
[45] L. Pachman,et al. TNFα-308A allele in juvenile dermatomyositis: Association with increased production of tumor necrosis factor α, disease duration, and pathologic calcifications , 2000 .
[46] L. Pachman,et al. TNFalpha-308A allele in juvenile dermatomyositis: association with increased production of tumor necrosis factor alpha, disease duration, and pathologic calcifications. , 2000, Arthritis and rheumatism.
[47] S. Gabriel,et al. The epidemiology of rheumatoid arthritis in Rochester, Minnesota, 1955-1985. , 1999, Arthritis and rheumatism.
[48] Jing-Ping Lin,et al. Familial clustering of rheumatoid arthritis with other autoimmune diseases , 1998, Human Genetics.
[49] S. Bale,et al. Familial autoimmunity in pedigrees of idiopathic inflammatory myopathy patients suggests common genetic risk factors for many autoimmune diseases. , 1998, Arthritis and rheumatism.
[50] C. Ober,et al. Molecular genetic studies of major histocompatibility complex genes in children with juvenile dermatomyositis: increased risk associated with HLA-DQA1 *0501. , 1991, Human immunology.
[51] A. Bohan,et al. Polymyositis and dermatomyositis (second of two parts). , 1975 .